Debra Ritzwoller to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications Debra Ritzwoller has written about Carcinoma, Non-Small-Cell Lung.
Connection Strength
2.744
-
Uptake of novel systemic therapy: Real world patterns among adults with advanced non-small cell lung cancer. Cancer Treat Res Commun. 2023; 36:100730.
Score: 0.856
-
Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2017 03; 18(2):189-197.e3.
Score: 0.534
-
Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung Cancer. J Oncol Pract. 2015 Sep; 11(5):356-62.
Score: 0.491
-
Comparative effectiveness of adjunctive bevacizumab for advanced lung cancer: the cancer research network experience. J Thorac Oncol. 2014 May; 9(5):692-701.
Score: 0.455
-
Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network. Lung Cancer. 2012 Dec; 78(3):245-52.
Score: 0.407